In my view the Neuren/Acadia merger scenario does not fit with the Baker Bros buyout exit strategy or to be in the best interest of NEU management/shareholders in the current biotech takeover environment. Acadia have destroyed existing shareholder value over a long period of time and appear incapable of turning things around.Pilchers currrent promotional activities do not look like he is preparing for a merger.
Kens
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.69 |
Change
1.150(9.17%) |
Mkt cap ! $1.730B | |||
| Open | High | Low | Value | Volume |
| $12.96 | $14.00 | $12.91 | $9.430M | 689.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 355 | $13.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.69 | 27 | 2 |
View Market Depth
| Last trade - 12.30pm 26/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |